Cargando…
Plasma Proteome Profiling to detect and avoid sample‐related biases in biomarker studies
Plasma and serum are rich sources of information regarding an individual's health state, and protein tests inform medical decision making. Despite major investments, few new biomarkers have reached the clinic. Mass spectrometry (MS)‐based proteomics now allows highly specific and quantitative r...
Autores principales: | Geyer, Philipp E, Voytik, Eugenia, Treit, Peter V, Doll, Sophia, Kleinhempel, Alisa, Niu, Lili, Müller, Johannes B, Buchholtz, Marie‐Luise, Bader, Jakob M, Teupser, Daniel, Holdt, Lesca M, Mann, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835559/ https://www.ncbi.nlm.nih.gov/pubmed/31566909 http://dx.doi.org/10.15252/emmm.201910427 |
Ejemplares similares
-
SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS
por: Buchholtz, Marie-Luise, et al.
Publicado: (2021) -
Revisiting biomarker discovery by plasma proteomics
por: Geyer, Philipp E, et al.
Publicado: (2017) -
High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion
por: Geyer, Philipp E, et al.
Publicado: (2021) -
From genotype to phenotype in human atherosclerosis - recent findings
por: Holdt, Lesca M., et al.
Publicado: (2013) -
Long Noncoding RNA ANRIL: Lnc-ing Genetic Variation at the Chromosome 9p21 Locus to Molecular Mechanisms of Atherosclerosis
por: Holdt, Lesca M., et al.
Publicado: (2018)